Jane Sharp, MD
Obstetrics & Gynecology · Cambridge, MANPI 1013926633
Payments from drug & device makers
Across 74 payments — averaging $56.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Exeltis, USA Inc.$193
- Myriad Women's Health, Inc.$138
- Astellas Pharma US Inc$127
- Boston Scientific$118
- Coopersurgical, Inc.$97
- plus $743 from 16 others
What the payments were for
- Speaking & faculty fees$2,50060%
- Food & beverage$1,65440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $2,738 |
| Exeltis, USA Inc. | 6 | $193 |
| Myriad Women's Health, Inc. | 1 | $138 |
| Astellas Pharma US Inc | 7 | $127 |
| Boston Scientific | 1 | $118 |
| Coopersurgical, Inc. | 4 | $97 |
| Myovant Sciences Inc. | 5 | $92 |
| Hologic Sales And Service, LLC | 3 | $83 |
| Pfizer | 4 | $68 |
| Bayer | 4 | $66 |
| Therapeuticsmd, Inc. | 4 | $62 |
| Mayne Pharma Commercial LLC | 3 | $60 |
| Evofem Biosciences, Inc. | 3 | $55 |
| Merck | 3 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Mylan Pharmaceuticals Inc. | 2 | $35 |
| Lupin Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $21 |
| BD | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPHION$118
How this compares
$4,154 in reported general payments places this provider in the 90th percentile of 910 obstetrics & gynecology providers in Massachusetts.
See all obstetrics & gynecology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 20 | $3,422 |
| YuvafemEstradiol | 19 | $2,565 |
| Estradiol | 30 | $1,633 |
| Estradiol (Once Weekly)Estradiol | 15 | $1,622 |
| ProgesteroneProgesterone, Micronized | 12 | $342 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cambridge
- Emily von BargenCambridge$12K
- Brigid MumfordCambridge$10K
- Katherine HanawayCambridge$8K
- Alyssa KratochvilFall River$1.9M
- Soheil Amin HanjaniBrockton$395K
- Alisa GoldbergBoston$341K
- Caroline MitchellBoston$293K
- Andrea EdlowBoston$273K
- Joelle LiemanBrighton$215K
- Michelle LightfootBoston$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.